↓ Skip to main content

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease

Overview of attention for article published in Frontiers in immunology, July 2022
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
18 Mendeley